Moreover, a combined cisplatin/SK2 decreased apoptosis (annexin V) in oral cancer cells more than in normal cells (S-G), indicating that cisplatin/SK2 induces selective apoptosis in oral cancer cells. Here, ANXA5 is linked to lip and oral cavity carcinoma.